paramyxovirina
pneumovirina
subfamili
paramyxovirida
famili
includ
sever
major
pathogen
human
anim
pneumovirina
taxonom
divid
pneumoviru
metapneumoviru
human
respiratori
syncyti
viru
hrsv
type
speci
pneumoviru
genu
singl
import
caus
lower
respiratori
tract
infect
rti
infanc
earli
childhood
member
pneumoviru
genu
includ
bovin
respiratori
syncyti
viru
brsv
ovin
respiratori
syncyti
viru
orsv
pneumonia
viru
mice
pvm
avian
pneumoviru
apv
previous
known
turkey
rhinotrach
viru
trtv
etiolog
agent
upper
rti
sole
member
recent
assign
metapneumoviru
metapneumovirus
associ
infect
diseas
mammal
classif
two
genera
base
primarili
gene
constel
metapneumovirus
lack
nonstructur
protein
gene
order
differ
pneumovirus
rsv
apv
past
decad
mani
etiolog
agent
respiratori
tract
ill
rti
howev
proport
ill
still
attribut
known
pathogen
isol
previous
undiscov
paramyxoviru
nasopharyng
aspir
sampl
taken
epidemiolog
unrel
children
netherland
suffer
rti
past
year
patient
age
year
infant
age
month
clinic
symptom
children
larg
similar
rti
caus
hrsv
rang
mild
respiratori
problem
sever
cough
bronchiol
pneumonia
often
accompani
high
fever
myalgia
vomit
patient
hospit
need
mechan
ventil
viru
isol
exhibit
paramyxoviruslik
morpholog
neg
contrast
electron
microscopi
close
relat
antigen
genet
base
sequenc
homolog
gene
constel
virus
seem
tent
new
member
metapneumoviru
genu
provision
name
human
metapneumoviru
hmpv
serolog
survey
show
age
five
year
virtual
children
netherland
expos
hmpv
viru
circul
human
least
half
centuri
viru
isol
character
within
diagnost
virolog
set
isol
unidentifi
virus
patient
netherland
rti
past
year
patient
person
inform
avail
eight
femal
age
month
age
year
virus
isol
sampl
collect
winter
month
unidentifi
viru
isol
replic
slowli
tertiari
monkey
kidney
tmk
cell
poorli
vero
cell
cell
could
propag
madin
darbi
canin
kidney
mdck
cell
chicken
embryo
fibroblast
cef
cytopath
effect
induc
viru
isol
virtual
indistinguish
caus
hrsv
characterist
syncytia
format
follow
rapid
intern
disrupt
cell
subsequ
detach
cultur
plate
cell
usual
display
cytopath
effect
day
post
inocul
slightli
later
cytopath
effect
induc
hrsvcontain
specimen
data
shown
day
viru
propag
viral
titer
cultur
averag
tissu
cultur
infecti
dose
per
ml
supernat
infect
tmk
cell
use
electron
microscopi
analysi
reveal
presenc
paramyxoviruslik
pleiomorph
particl
rang
nm
short
envelop
project
rang
nm
fig
similar
paramyxovirus
select
hrsv
parainfluenza
viru
isol
nucleocapsid
rare
observ
consist
biochem
properti
envelop
virus
paramyxovirida
standard
chloroform
result
reduct
tmk
cell
virusinfect
tmk
cellcultur
supernat
display
hemagglutin
activ
turkey
chicken
guinea
pig
erythrocyt
tmkcell
cultur
viru
replic
found
depend
trypsin
combin
virolog
data
indic
newli
identifi
viru
member
paramyxovirida
famili
isol
rna
supernat
tmk
cell
infect
unidentifi
viru
isol
revers
transcript
rt
pcr
analys
use
primer
set
specif
known
paramyxovirus
human
parainfluenza
viru
hpiv
type
mump
viru
measl
viru
hrsv
simian
viru
type
sendai
viru
newcastl
diseas
viru
ndv
carri
rtpcr
assay
low
stringenc
order
detect
potenti
relat
virus
use
rna
isol
homolog
viru
stock
posit
control
wherea
control
react
posit
respect
virusspecif
primer
newli
identifi
viru
isol
data
shown
indic
viru
close
relat
virus
primer
set
select
next
inocul
ferret
guinea
pig
intranas
two
viru
isol
without
prior
purif
rais
virusspecif
antisera
anim
display
clinic
symptom
antisera
react
immun
fluoresc
assay
ifa
cell
infect
panel
paramyxovirus
orthomyxovirus
hpiv
type
hrsv
influenza
viru
type
b
anim
seroconvert
shown
viru
neutral
assay
ifa
homolog
virus
next
test
unidentifi
viru
isol
guinea
pig
ferret
pre
postinfect
sera
tmk
cell
cultur
infect
viru
isol
react
posit
ifa
postinfect
anim
sera
indic
serolog
relat
ident
rappcr
obtain
sequenc
inform
unknown
viru
isol
use
random
pcr
amplif
strategi
known
rappcr
ref
end
infect
tmk
cell
one
viru
isol
isol
serv
control
sequenc
differenti
display
band
specif
unidentifi
viru
use
deduc
aminoacid
sequenc
search
homolog
sequenc
genbank
databas
use
blast
softwar
http
wwwncbinlmnihgovblast
fragment
display
resembl
apvtrtv
sequenc
fragment
locat
gene
code
nucleoprotein
n
fragment
matrix
protein
fragment
fusion
protein
f
fragment
polymeras
protein
l
fragment
fig
exclud
possibl
contamin
human
sampl
apvtrtv
viru
laboratori
next
design
pcr
primer
complet
sequenc
inform
end
viral
genom
base
rappcr
fragment
well
publish
leader
trailer
sequenc
fig
total
gener
kilobas
sequenc
inform
viral
genom
analys
sequenc
fragment
reveal
absenc
open
read
frame
orf
extrem
end
viral
genom
fig
posit
put
f
orf
immedi
adjac
put
orf
fig
genom
organ
resembl
metapneumoviru
apv
consist
sequenc
homolog
note
howev
genom
organ
hmpv
simpli
deduc
apv
requir
analysi
translat
sequenc
n
p
f
orf
align
aminoacid
sequenc
hrsv
apv
fig
n
align
reveal
homolog
hrsv
homolog
apv
aminoacid
sequenc
p
reveal
homolog
hrsv
apv
hrsv
apv
f
hrsv
homolog
apv
phylogeni
indic
relationship
newli
identifi
viru
isol
member
pneumovirina
phylogenet
tree
construct
base
n
p
f
orf
virus
four
phylogenet
tree
newli
identifi
viru
isol
close
relat
apv
fig
four
serotyp
apv
apv
serotyp
c
metapneumoviru
found
primarili
bird
unit
state
show
closest
resembl
newli
identifi
viru
howev
limit
sequenc
inform
apv
serotyp
avail
experiment
infect
bird
cynomolgu
macaqu
sinc
hmpv
appear
close
relat
apv
wish
test
whether
hmpv
primari
human
pathogen
avian
pathogen
also
infect
human
inocul
four
juvenil
turkey
four
juvenil
chicken
four
juvenil
cynomolgu
macaqu
hmpv
conjunctiva
respiratori
tract
collect
cloaca
andor
throat
sampl
test
presenc
hmpv
rtpcr
three
week
followup
none
bird
show
clinic
sign
viru
replic
determin
rtpcr
use
rna
isol
throat
cloaca
swab
contrast
viru
replic
effici
respiratori
tract
four
monkey
shown
rtpcr
rna
isol
throat
swab
wherea
viral
rna
detect
sampl
taken
day
viru
replic
peak
day
inocul
two
monkey
present
mild
upper
respiratori
tract
sign
upon
histolog
analysi
prove
associ
suppur
rhiniti
data
shown
although
detail
patholog
virolog
immunolog
analys
incomplet
present
preliminari
data
indic
hmpv
primat
pathogen
associ
respiratori
diseas
genet
heterogen
hmpv
isol
next
amplifi
small
part
n
f
l
orf
nucleotid
respect
viru
isol
rtpcr
sequenc
fragment
directli
minim
possibl
error
introduc
amplif
procedur
phylogenet
analys
reveal
signific
sequenc
variat
exist
two
potenti
genet
cluster
hmpv
isol
obtain
netherland
fig
nucleotid
sequenc
ident
isol
within
cluster
four
fragment
wherea
sequenc
ident
isol
two
cluster
variat
similar
n
f
l
fragment
seem
correl
year
viru
isol
indic
first
two
number
name
isol
genet
cluster
might
repres
subgroup
newli
identifi
viru
analog
pneumovirus
rsv
seropreval
studi
preval
viru
human
popul
test
sera
human
differ
age
categori
indirect
ifa
use
tmk
cell
infect
one
unidentifi
viru
isol
analysi
reveal
children
age
month
antibodi
viru
toward
age
virtual
children
becom
seroposit
tabl
addit
serum
sampl
test
indirect
ifa
test
viru
neutral
assay
sampl
result
viru
neutral
assay
titer
correl
result
obtain
indirect
ifa
titer
four
sampl
posit
ifa
titer
neg
viru
neutral
test
titer
one
serum
sampl
react
neg
ifa
titer
posit
viru
neutral
test
titer
indirect
ifa
conduct
sera
taken
human
age
year
reveal
seropreval
indic
viru
circul
human
popul
year
addit
test
number
sera
viru
neutral
assay
confirm
ifa
data
tabl
rang
antibodi
titer
appear
higher
individu
older
year
compar
children
month
observ
could
relat
boost
antibodi
respons
consequ
reinfect
close
relat
viru
howev
detail
serolog
virolog
analys
requir
substanti
specul
describ
character
new
member
paramyxovirida
famili
isol
children
rti
netherland
children
present
clinic
symptom
reminisc
caus
hrsv
infect
rang
mild
upper
respiratori
tract
diseas
sever
bronchiol
pneumonia
seen
hrsvinfect
children
young
hmpvinfect
children
appear
requir
hospit
mechan
ventil
whether
hmpv
infect
caus
rti
formal
conclud
present
data
importantli
acut
convalesc
pair
sera
avail
children
hmpv
isol
howev
consid
viru
identifi
hmpvinfect
children
hmpv
isol
sampl
taken
children
two
year
age
without
respiratori
symptom
shown
causal
relationship
seem
like
experiment
infect
cynomolgu
macaqu
support
conclus
base
data
propos
name
human
metapneumoviru
hmpv
hmpv
prove
paramyxoviruslik
morpholog
electron
microscopi
chloroformsensit
replic
optim
trypsindepend
manner
tmk
cell
clinic
symptom
hmpvinfect
children
characterist
cytopath
effect
lack
haemagglutin
activ
suggest
viru
might
relat
hrsv
although
paramyxovirus
hemagglutin
activ
pneumovirus
genet
analys
put
n
p
f
gene
reveal
hmpv
show
higher
sequenc
homolog
recent
propos
genu
metapneumoviru
averag
compar
genu
pneumoviru
averag
genom
organ
similar
apvtrtv
contrast
genom
organ
pneumovirus
metapneumovirus
lack
gene
differ
posit
gene
l
absenc
orf
f
gene
viru
lack
gene
adjac
n
agreement
first
identifi
nonavian
member
metapneumoviru
genu
howev
sequenc
inform
becom
avail
entir
genom
organ
hmpv
definit
classif
viru
possibl
four
serotyp
apv
describ
serotyp
c
close
relat
hmpv
base
n
p
f
gene
howev
serotyp
limit
sequenc
inform
f
gene
avail
genbank
serotyp
b
n
f
sequenc
avail
hrsv
apv
differ
genet
serolog
subtyp
describ
also
found
evid
genet
variat
hmpv
isol
although
tempt
specul
subgroup
hmpv
isol
repres
differ
serotyp
hmpv
sequenc
analys
part
hmpv
genom
isol
obtain
differ
geograph
locat
well
detail
serolog
studi
need
support
hypothesi
serolog
survey
reveal
hmpv
commonli
infect
children
repeat
isol
viru
clinic
sampl
children
rti
indic
hmpv
infect
may
consider
clinic
econom
impact
new
diagnost
assay
base
viru
detect
serolog
allow
detail
analysi
incid
clinic
econom
impact
newli
identifi
human
viru
get
idea
potenti
impact
viru
rti
test
nasopharyng
aspir
sampl
collect
winter
season
children
present
rti
erasmu
univers
medic
center
neg
rsv
influenza
b
virus
parainfluenza
viru
type
human
rhinoviru
corona
viru
seven
sampl
test
prove
posit
hmpv
rtpcr
indic
winter
season
approxim
unexplain
rti
may
associ
hmpv
minor
differ
ifa
viru
neutral
result
sampl
may
due
sever
factor
igg
serum
antibodi
detect
ifa
viru
neutral
antibodi
gener
direct
surfac
glycoprotein
sensit
two
assay
may
differ
differ
serotyp
hmpv
may
exist
latter
suggest
particular
interest
sinc
one
isol
use
ifa
viru
neutral
potenti
give
rise
fals
neg
result
use
sera
rais
genet
distinct
hmpv
isol
shown
fig
hmpv
seem
close
relat
apv
specul
human
viru
origin
bird
analysi
serum
sampl
taken
human
reveal
hmpv
widespread
human
popul
least
half
centuri
indic
possibl
zoonot
event
must
taken
place
question
aris
viru
remain
unidentifi
mani
year
first
mani
virolog
laboratori
use
continu
cell
line
viru
isol
hmpv
seem
replic
effici
second
hmpv
display
slow
replic
kinet
vitro
may
therefor
remain
undetect
third
replic
hmpv
invitro
appear
trypsin
depend
mani
earlier
studi
find
respiratori
pathogen
use
trypsin
final
appar
lack
crossreact
serolog
assay
perform
low
nucleotid
sequenc
homolog
known
human
viral
pathogen
make
unlik
detect
hmpv
standard
serolog
molecular
techniqu
pringl
eglin
describ
serolog
evid
unidentifi
pvmlike
pneumoviru
frequent
infect
feel
unlik
hmpv
pvmlikeviru
describ
pringl
eglin
number
reason
first
hightit
sera
specif
sever
paramyxovirus
includ
pvm
rsv
fail
react
immunofluoresc
studi
hmpvinfect
tmk
cell
target
data
shown
second
human
serum
sampl
pvmspecif
antibodi
measur
elisa
furthermor
pvm
supposedli
pvmlike
viru
hemagglutin
activ
wherea
evid
hmpv
final
genom
organ
pvm
similar
rsv
thu
differ
hmpv
identif
tent
new
member
metapneumoviru
genu
may
aid
develop
diagnost
assay
vaccin
antivir
agent
viral
rti
past
decad
viru
diagnost
hospitalbas
laboratori
collect
nasopharyng
aspir
children
suffer
rti
sampl
routin
test
presenc
virus
direct
immun
fluoresc
assay
dif
use
antibodi
virus
known
caus
rti
hpiv
type
hrsv
influenza
viru
type
b
viru
isol
use
rapid
shellvial
techniqu
tmk
cell
cef
well
variou
cell
line
vero
mdck
sampl
show
cytopath
effect
passag
neg
dif
test
indirect
ifa
use
virusspecif
antibodi
influenza
viru
type
b
c
hrsv
hpiv
type
measl
viru
mump
viru
sendai
viru
ndv
although
mani
case
etiolog
agent
could
identifi
specimen
yield
cytopath
effect
cell
cultur
neg
virus
test
rais
virusspecif
antisera
ml
volum
virusinfect
tmk
cellcultur
supernat
differ
viru
isol
contain
approxim
use
inocul
guinea
pig
ferret
intranas
without
prior
purif
sampl
taken
day
day
infect
anim
bled
cardiac
punctur
pre
postinfect
sera
use
neg
posit
refer
sera
respect
sera
test
reactiv
previous
describ
virus
dif
ifa
describ
cultur
viru
isol
tmk
cell
eagl
mem
hank
salt
supplement
trypsin
without
serum
inocul
plate
incub
maximum
time
medium
chang
week
cultur
check
daili
cytopath
effect
degre
cytopath
effect
differ
slightli
isol
cultur
test
day
indirect
ifa
use
ferret
antisera
rais
one
isol
electron
microscopi
analys
viru
concentr
infect
cellcultur
supernat
microcentrifug
pellet
resuspend
pb
potassium
tungstat
acid
pta
stain
inspect
neg
contrast
electron
standard
hemagglutin
assay
chloroform
sensit
test
dif
ifa
perform
viru
neutral
assay
perform
tmk
cell
serial
dilut
human
anim
sera
start
hmpv
follow
procedur
sinc
cytopath
effect
alway
easi
detect
ifa
use
determin
viru
neutral
titer
viru
neutral
titer
defin
reciproc
highest
dilut
serum
sampl
result
neg
ifa
inhibit
cytopath
effect
cell
cultur
rna
isol
supernat
infect
cell
cultur
sucros
gradient
fraction
use
high
pure
rna
isol
kit
accord
instruct
manufactur
roch
diagnost
almer
netherland
rtpcr
assay
perform
accord
establish
techniqu
primer
specif
panel
paramyxovirus
test
condit
avail
upon
request
rappcr
viru
concentr
infect
tmkcell
supernat
ultracentrifug
sucros
gradient
gradient
fraction
inspect
presenc
viruslik
particl
electron
microscopi
polyacrylamid
gel
electrophoresi
follow
silver
stain
approxim
sucros
fraction
appear
contain
nucleocapsid
use
rna
isol
rappcr
rappcr
perform
essenti
primer
sequenc
use
avail
upon
request
differenti
display
fragment
specif
hmpv
purifi
gel
qiaquick
gel
extract
kit
qiagen
leusden
netherland
clone
vector
invitrogen
groningen
netherland
accord
instruct
manufactur
rappcr
product
clone
vector
sequenc
oligonucleotid
dna
fragment
obtain
rtpcr
purifi
agaros
gel
use
qiaquick
gel
extract
kit
qiagen
leusden
netherland
sequenc
directli
oligonucleotid
use
rtpcr
assay
sequenc
analys
perform
use
dyenam
et
termin
sequenc
kit
amersham
pharmacia
biotech
roosenda
netherland
abi
automat
dna
sequenc
pe
appli
biosystem
nieuwerkerk
aan
den
tjssel
netherland
accord
instruct
manufactur
phylogenet
tree
dna
sequenc
align
use
clustalw
softwar
packag
maximum
likelihood
tree
gener
use
dnaml
softwar
packag
phylip
program
use
bootstrap
jumbl
bootstrap
valu
comput
consensu
tree
creat
consens
hmpv
sequenc
avail
genbank
access
number
sequenc
use
avail
genbank
access
number
hrsv
orf
brsv
orf
pvm
n
apva
n
apvb
n
apvc
n
pvm
p
apva
p
apvc
p
pvm
apva
apvb
apvc
pvm
f
apva
f
apvb
f
apvc
f
